Tricol Biomedical Inc (Tricol Biomedical), a subsidiary of Tricol International Group Ltd, is a medical device company that develops, manufactures and markets hemostasis and infection control products. The company’s products include chitogauze pro and guardacare pro, hemcon guardiva, hemcon patch pro, guardacarexr surgical and hemcon bandages pro. It offers products under the brands OneStop, HemCon and m.doc. Tricol Biomedical offers its products for use in the treatment of trauma and surgery and dressing products, military medics, paramedics, first responders and consumers. The company supplies its products through distributors in Europe, Asia-Pacific and the Middle East. Tricol Biomedical is headquartered in Portland, Oregon, the US.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Tricol Biomedical Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Table of Contents
- Tricol Biomedical Inc Company Overview
- Tricol Biomedical Inc Company Snapshot
- Tricol Biomedical Inc Pipeline Products and Ongoing Clinical Trials Overview
- Tricol Biomedical Inc - Pipeline Analysis Overview
- Tricol Biomedical Inc - Key Facts
- Tricol Biomedical Inc - Major Products and Services
- Tricol Biomedical Inc Pipeline Products by Development Stage
- Tricol Biomedical Inc Pipeline Products Overview
- CGHD+DW Device
- CGHD+DW Device Product Overview
- Chitosan Endoluminal Hemostatic Dressing Catheter Device
- Chitosan Endoluminal Hemostatic Dressing Catheter Device Product Overview
- Hemostatic Urinary Catheter Device (HUCD)
- Hemostatic Urinary Catheter Device (HUCD) Product Overview
- Plasfusion Lyophilized Plasma System
- Plasfusion Lyophilized Plasma System Product Overview
- Tricol Biomedical Inc - Key Competitors
- Tricol Biomedical Inc - Key Employees
- Tricol Biomedical Inc - Locations And Subsidiaries
- Head Office
- Other Locations & Subsidiaries
- Recent Developments
- Tricol Biomedical Inc, Recent Developments
- May 05, 2021: Tricol Biomedical launches sales and marketing agency agreement with NorthStar Sales Alliance
- Jan 06, 2021: Medline Expanding Clinician Access to Products Designed to Safely Control Bleeding
- May 06, 2015: Collaboration Between HemCon and OHSU is Awarded Additional NIH Grant with Total Value of $1.1M for the Development of a Transurethral Hemostatic Device
- Apr 07, 2015: HemCon Medical Technologies Launches into Chinese Market
- Mar 24, 2015: HemCon Medical Technologies Receives 2015 Best of Portland Award
- Feb 17, 2015: HemCon Medical Technologies Continues Transition to Innovation Leader
- Nov 03, 2014: HemCon Medical Technologies Awarded Hemostasis and Compression Products Agreement With Premier
- Sep 16, 2014: HemCon Medical Technologies Projects Strong Third Quarter Revenues
- Sep 03, 2014: HemCon Medical Technologies Announces Strategic Facility Relocation to Support Rapid Growth and New Product Development
- Jun 12, 2014: HemCon Medical Technologies Announces New Research on ChitoGauze® Published in Leading European Trauma Journal
- Appendix
- Methodology
- About the Publisher
- Contact the Publisher
- Disclaimer
- Tricol Biomedical Inc Pipeline Products and Ongoing Clinical Trials Overview
- Tricol Biomedical Inc Pipeline Products by Equipment Type
- Tricol Biomedical Inc Pipeline Products by Indication
- Tricol Biomedical Inc, Key Facts
- Tricol Biomedical Inc, Major Products and Services
- Tricol Biomedical Inc Number of Pipeline Products by Development Stage
- Tricol Biomedical Inc Pipeline Products Summary by Development Stage
- CGHD+DW Device - Product Status
- CGHD+DW Device - Product Description
- Chitosan Endoluminal Hemostatic Dressing Catheter Device - Product Status
- Chitosan Endoluminal Hemostatic Dressing Catheter Device - Product Description
- Hemostatic Urinary Catheter Device (HUCD) - Product Status
- Hemostatic Urinary Catheter Device (HUCD) - Product Description
- Plasfusion Lyophilized Plasma System - Product Status
- Plasfusion Lyophilized Plasma System - Product Description
- Tricol Biomedical Inc, Key Employees
- Tricol Biomedical Inc, Subsidiaries
- Glossary
- Tricol Biomedical Inc Pipeline Products by Equipment Type
- Tricol Biomedical Inc Pipeline Products by Development Stage
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- San Jose Surgical Supply Inc
- Crosstex International Inc
- Bisco Inc
- Aseptico Inc
